Articles

SEC accuses Indy cancer firm of being a sham

The SEC says the CEO of locally based biomedical firm Xytos Inc. has committed securities fraud
since 2010 by repeatedly publishing false information to investors about the company. Timothy Cook denies the accusations.

Read More

NASDAQ breakdown ramps pressure to take actions

The latest high-tech disruption in the financial markets ratchets up the pressure on NASDAQ and other electronic exchanges to take steps to avoid future breakdowns and manage them better if they do occur.

Read More

Mighty Oxford Financial loses big case with client

An arbitrator ordered the Carmel financial-advisory firm to pay $2.2 million to Reid Hospital & Health Services of Richmond. The dispute involved a delay in executing trades in 2011 that the hospital alleged cost it $2.5 million.

Read More

World looks to Bernanke to clarify stimulus plans

Financial markets have been gyrating in the 3½ weeks since Bernanke told Congress the Fed might scale back its effort to keep long-term rates at record lows within "the next few meetings"— earlier than many had assumed.

Read More

Stocks swoon after weak economic reports

Companies like miners, banks and chemical makers, whose fortunes are most closely tied to the prospects for growth, fell the most. That's a sign investors are becoming less confident in the U.S. economy.

Read More

Stocks soar to all-time high on employment news

A stronger-than-expected pickup in hiring last month lifted the stock market early Friday, pushing the Dow Jones industrial average above 15,000 and the Standard and Poor's 500 index above 1,600 points for the first time.

Read More

Dow record doesn’t impress Wall Street workers

There were no signs of a celebration on Wall Street after the Dow Jones industrial average closed at an all-time high Tuesday. Maybe the memories of the financial meltdown are too fresh, or outlook for the economy is too uncertain.

Read More